Agilent Technologies Inc vs Trump Media and Technology Group Corp — how do they compare? Agilent Technologies Inc trades at $148.13 (market cap $42.22B), while Trump Media and Technology Group Corp trades at $8.39 (market cap $2.48B). The key difference: Agilent Technologies Inc is far larger — about 17× Trump Media and Technology Group Corp's market cap, and Agilent Technologies Inc pays a 0.68% dividend while Trump Media and Technology Group Corp pays none. Which is the better fit depends on your goals.
| A | DJT | |
|---|---|---|
Market Cap | $42.22B | $2.48B |
Sector | Health | Media |
52-Week High | $157.20 | $18.50 |
52-Week Low | $110.24 | $7.06 |
Enterprise Value | $43.77B | $2.54B |
Dividend Yield | 0.68% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $148.77, up 0.03% on the day, near its consensus price target of $154.90. The stock shows bullish technical signals with strong moving average support, though RSI indicates overbought conditions. Recent earnings beat expectations in Q1 2026, and the company maintains robust profitability with a 19.55% net income margin. Key developments include FDA and EU regulatory approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its biopharma portfolio.
Outlook remains positive with analyst consensus at Buy (77.5%) and a projected 4.1% upside to the price target. Risks include elevated valuation multiples (P/E 30.02) and dependence on healthcare sector growth. Earnings on August 26, 2026, will be critical for validating continued momentum amid competitive and macroeconomic pressures.
DJT stock declined 8.84% to $8.56 amid widening quarterly losses and negative technical momentum. The company reported a $238.1 million Q2 2026 net loss primarily from digital asset declines, despite 89% revenue growth to $1.67 million. Technical indicators show bearish momentum with price near key support at $8, while fundamental metrics reveal extreme valuation concerns with a P/S ratio of 547.62 and negative profit margins exceeding -28,000%.
The outlook remains challenging with persistent cash burn, unsustainable valuation multiples, and negative earnings trajectory. Investment opportunities appear limited given the company's minimal revenue base and ballooning losses, while risks include continued operational losses, digital asset volatility exposure, and competitive pressures in social media. Analyst sentiment remains overwhelmingly negative with Strong Sell ratings predominating.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →